The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Karmele Valencia(Clinica Universidad de Navarra), Silvestre Vicent(Chartered Institute of Management Accountants)
Cited by 50
Related Papers
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
|Molecular Cancer|2018|306
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
|Nature Communications|2017|194
miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization
|Molecular Oncology|2014|164
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
|Molecular Cancer|2023|24
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
|Nature Communications|2023|23